ALLR - Allarity Therapeutics reports Q1 GAAP EPS of -$22.14
2024-05-15 09:18:43 ET
More on Allarity Therapeutics
- Allarity exceeds Nasdaq's minimum equity requirement
- Allarity rallies on conclusion of mid-stage trial for its ovarian cancer treatment after showing clinical benefit
- Seeking Alpha’s Quant Rating on Allarity Therapeutics
- Historical earnings data for Allarity Therapeutics
- Financial information for Allarity Therapeutics